TA
FATE icon

TFG Advisers’s Fate Therapeutics FATE Stock Holding History

TFG Advisers’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,001
Closed -$310K – 199
2022
Q1 		$310K Sell
8,001
-263
-3% -$10.2K 0.14% 150
2021
Q4 		$484K Sell
8,264
-407
-5% -$23.1K 0.21% 119
2021
Q3 		$514K Buy
8,671
+274
+3% +$21.5K 0.25% 105
2021
Q2 		$729K Sell
8,397
-147
-2% -$11.8K 0.35% 81
2021
Q1 		$704K Sell
8,544
-74
-0.9% -$7.09K 0.36% 77
2020
Q4 		$783K Buy
8,618
+1,111
+15% +$69K 0.41% 70
2020
Q3 		$300K Buy
+7,507
New +$262K 0.17% 134
2020
Q1 		– Sell
-2,184
Closed -$42K – 244
2019
Q4 		$42K Buy
+2,184
New +$34.7K 0.02% 284

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return